CompletedPhase 2NCT00528398
Idarubicin and High-Dose Cytarabine in Treating Patients With Acute Myeloid Leukemia
Studying Acute erythroid leukemia
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- City of Hope Medical Center
- Principal Investigator
- Anthony S. Stein, MDCity of Hope Comprehensive Cancer Center
- Intervention
- cytarabine(drug)
- Enrollment
- 111 enrolled
- Eligibility
- 16-60 years · All sexes
- Timeline
- 1994 – 2015
Study locations (2)
- Banner Good Samaritan Medical Center, Phoenix, Arizona, United States
- City of Hope Comprehensive Cancer Center, Duarte, California, United States
Collaborators
National Cancer Institute (NCI)
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT00528398 on ClinicalTrials.govOther trials for Acute erythroid leukemia
Additional recruiting or active studies for the same condition.